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ORIGINAL ARTICLE

Nutritional Status in Patients with Hepatitis C

Faisal Wasim Ismail, Rustam A. Khan, Lubna Kamani, Ashfaq A. Wadalawala, Hasnain Ali Shah,
Saeed S. Hamid and Wasim Jafri

ABSTRACT
Objective: To assess the nutritional status via the SGA (subjective global assessment) screening tool of patients at all
stages of hepatitis C virus (HCV) liver disease.
Study Design: Descriptive study.
Place and Duration of Study: Out-patient Clinics of the Aga Khan University Hospital, Karachi, conducted from October
2009 to January 2011.
Methodology: Patients with hepatitis C virus infection and their HCV-negative attendants were enrolled from the outpatient clinics, and categorized into 4 groups of 100 patients each: healthy controls (HC), those with chronic hepatitis C
infection (CHC), compensated cirrhotics (CC) and decompensated cirrhotics (DC). The validated subjective global
assessment (SGA) tool was used to assess nutritional status.
Results: A total of 400 patients were enrolled. Most of the patients in the HC group were class 'A' (best nutritional status).
In contrast, the majority (64%) in the DC group were in the class 'C' (worst status). The compensated cirrhosis (CC) group
showed that 90% of patients were malnourished, while 98% of all patients were malnourished in the DC group,
predominantly class 'C'. Most importantly, 14% of patients with chronic hepatitis C (CHC) also scored a 'B' on the SGA;
which when compared to HC was statistically significant (p=0.005). As the groups progressed in their disease from CHC
to DC, the transition in nutritional status from 'A' to 'C' between groups was statistically significant.
Conclusion: Malnutrition occurs early in the course of HCV, and progresses relentlessly throughout the spectrum of HCV
disease.
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INTRODUCTION
The relationship between malnutrition and liver disease
has been assuming greater significance due to the
recognition that it is associated with adverse clinical
outcomes. Malnutrition is present in 65-90% of patients
with advanced liver disease and in almost 100% of
candidates for liver transplantation.1,2 Cirrhotic patients
who are malnourished not only have a higher morbidity,
but also an increased mortality rate.3,4 The severity of
malnutrition correlates directly with the progression of
the liver disease.5,6
The chief reason for the malnutrition in these patients is
poor oral intake, which may be due to a variety of
causes. Vitamin A and or Zinc deficiency may give rise
to an altered sense of taste.7 The dietary restrictions that
are frequently advised to these patients, such as
restriction of salt, protein, and fats, can discourage
adequate oral intake by rendering food a bland taste.
Weakness, fatigue, and encephalopathy may also
contribute to decreased oral intake.8
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Malabsorption is another vital reason why patients with
advanced hepatic disease become malnourished. A
reduction in the bile-salt pool may lead to fat
malabsorption,9 or bacterial overgrowth may result from
impaired small-bowel motility.10 Portal hypertension
has also been named as a cause of malabsorption
and protein loss from the gastrointestinal tract.11,12 In
addition, the administration of medications used in
the treatment of hepatic encephalopathy may also
contribute to malabsorption.13
Hepatitis C virus liver disease spans a spectrum from
chronic hepatitis C to compensated cirrhosis, and to
finally decompensated cirrhosis. While, the overt
malnutrition associated with cirrhosis has been
documented in literature, there is little data regarding the
nutritional status of patients who have simple chronic
hepatitis C, with no evidence of severe liver dysfunction,
apart from raised transaminases, or the compensated
cirrhotic, and how they compare to the normal population.
The rationale for this study is all the more relevant in the
developing world, where lack of education and
awareness, and inaccessibility to good health care lead
to misinformation. Often faith healers, traditional
medicine specialists, quacks and family members
enforce strict and unnecessary dietary restrictions,
predominantly of fat and protein, which initiate and
worsen nutritional status. Given these facts, it would be
prudent to screen all patients with liver disease for
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nutritional abnormalities to identify those at risk of
developing malnutrition.14
Subjective global assessment (SGA) is a tool that
combines multiple elements of nutritional assessment to
classify the severity of malnutrition from mild to
severe.15 These components are recent weight loss,
changes in dietary intake, gastrointestinal symptoms,
functional capacity, signs of muscle wasting, and the
presence of presacral or pedal oedema. The SGA is an
excellent tool to assess nutritional status in many
diseases, and has an interobserver reproducibility rate
of 80%.16 Simple bedside methods like the SGA have
been shown to identify malnutrition adequately; the use
of more complex scoring systems has not proved
superior.17
The objective of this study was to assess the nutritional
status via the SGA (subjective global assessment)
screening tool of patients at all stages of hepatitis C
virus (HCV) liver disease.

METHODOLOGY
Patients were enrolled from the Out-patient Hepatology
Clinics at the Aga Khan University Hospital in a
prospective manner during 15 months from October
2009 till January 2011. After a detailed assessment by
the physician which included a history and examination,
patients were categorized into 4 distinct populations of
100 patients each: healthy controls (HC), those with
chronic hepatitis C infection (CHC), compensated
cirrhotics (CC) and decompensated cirrhotics (DC).

Compensated cirrhotics (CC) were patients who had no
history of decompensation, and an ultrasound showing
features of cirrhosis ± portal hypertension, but no ascites.
Finally, decompensated cirrhotics (DC) were those who
had either a history or physical examination compatible
with a diagnosis of decompensation, or ultrasound
demonstrating free fluid in the abdomen.
Decompensation was defined as any episode of variceal
bleeding, ascites, or porto-systemic encephalopathy. The
SGA form was filled in all instances by the consultant
physician himself. A nutritional history was also noted,
with particular reference to any protein or fat restriction.
Written, informed consent was taken from all the study
participants, and the study was approved by the
University Ethics Committee.
A descriptive analysis was done for demographic
features and results are presented as mean ± standard
deviation for quantitative variables and number (percentage) for qualitative variables among the different
groups (CHC, CC, DC and HC). Analysis of variance
(ANOVA) was performed to determine any statistical
difference among the groups and the age, total bilirubin,
prothrombin time and serum albumin. Differences in
proportions were assessed among the groups and
gender by using the chi-square test. Difference in
proportion among the nutritional classes and groups
were assessed by chi-square test.
All analyses were conducted by using the Statistical
Package for Social Science [SPSS - Release 18.0,
standard version, copyright © SPSS; 1989-02]. All
p-values were two sided and considered as statistically
significant if p < 0.05.

Healthy controls (HC) were the accompanying household members (gender and closest age matched) of the
patients who were assessed to be healthy after a
history, examination and a negative HCV antibody
screening test. No other tests were performed, as they
were asymptomatic and were negative for HCV disease.
The controls were exposed to the same socioeconomic
conditions as the patients, and screening of family
members of the index patient is standard practice at the
study centre.

A total of 400 patients were enrolled, equally divided
amongst the 4 groups. Gender was comparable in all 4
groups. The values of serum total bilirubin, albumin and
prothrombin time became worse as the disease
progressed from CHC to DC (Table I).

Chronic hepatitis C infection (CHC) patients were
those who had evidence of HCV viremia, raised
transaminases, normal liver synthetic function, and an
ultrasound of the liver showing absence of portal hypertension, such as a dilated portal vein, or splenomegaly.

The HC group had a mean age of 31.56±4.67 years.
Most of the healthy control group (HC) was in SGA class
'A', and there were none in class 'C'. In contrast, the
majority (64%) in the decompensated cirrhosis (DC)
group were in the class 'C', while only 2% (n=2) were

RESULTS

Table I: Comparison of variables among the studied groups.
Characteristics

CHC (n=100)

CC (n=100)

DC (n=100)

HC (n=100)

p-value

Age (years)

33.63 ± 4.51

45.56 ± 2.79

50.66 ± 4.73

31.56 ± 4.67

< 0.001

Male

68 (68)

71 (71)

67 (67)

68 (68)

0.93

Female

32 (32)

29 (29)

33 (33)

32 (32)

–

1.10 ± 0.15

1.60 ± 0.24

2.63 ± 0.44

–

< 0.001

Gender

Total bilirubin (mg/dl)
Serum albumin (mg/dl)

3.53 ± 0.23

2.98 ± 0.34

2.46 ± 0.38

–

< 0.001

Prothrombin time prolongation from control in seconds

2.35 ± 0.29

3.48 ± 0.33

6.22 ± 0.58

–

< 0.001

CHC: Chronic hepatitis C; CC: Compensated cirrhosis; DC: Decompensated cirrhosis;
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HC: Healthy controls.
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in the 'A' category. The compensated cirrhosis (CC)
group showed that 90% of patients were malnourished,
while 98% of all patients were malnourished in the
DC group, predominantly class 'C'. Most importantly,
14% of patients with chronic hepatitis C (CHC) also
scored a 'B' on the SGA; which when compared to HC
was statistically significant (p=0.005). As the groups
progressed in their disease from CHC to DC, the
transition in nutritional status from 'A' to 'C' between
groups was statistically significant (Figure 1).

Figure 1: Comparison of nutritional status among the groups based on
subjective global assessment (SGA) tool.
HC vs. CHC, p-value=0.005
CHC vs. CC, p < 0.001
CC vs. DC, p < 0.001

DISCUSSION
This is the first study to document the nutritional status
of patients across the whole spectrum of hepatitis C
virus infection. Most of the literature has been devoted
to the nutritional aspects of cirrhotic and pre- transplant
patients.18,19 This study shows that the downslide
begins much earlier, even before cirrhosis sets in. Even
when these patients visit their physicians for other
ailments, the nutritional deficiency may not be realized,
so the process continues unabated, until frank
malnutrition sets in.
The vast majority of patients across all the cohorts were
on a diet that was restricted in protein and fat content in
varying amounts. This stems from the false but firm
belief that when the liver is affected, it should not be
“burdened” with calories. This practice, which is
endorsed not only by patients and their families, but also
unfortunately by ill-informed physicians, is likely the
reason why upto 14% of patients with just CHC are
moderately malnourished, and that the majority of
CC patients are moderately or overtly malnourished
(90%).
The most important finding in this study was seen
between the HC and the CHC cohort of patients, and
this is where the focus of nutritional intervention should
be. Patients with CHC should be expected to have the
same level of nutrition as HC, as no significant liver

damage has occurred, but this was not the case. Upto
14% of such patients had a moderate nutritional value,
most likely a result of caloric and protein restriction,
which was statistically significant when compared to HC.
Poor nutritional status contributes to fatigue, anaemia,
and infection, all of which impair successful HCV
treatment, as treatment itself causes cytopenias and
profound fatigue. Patients who are in better nutritional
health are more likely to tolerate treatment side-effects,
require less disruption of treatment, or dose reductions,
and, therefore, have a more successful outcome, as
compared to those who are nutritionally depleted.20,21
The CC group also had a very alarmingly small number
of patients who were well nourished (10%). The vast
majority (56%) were moderately nourished, and a
significant number (34%) were malnourished. The main
reason for such a high number of cirrhotics to be
malnourished is protein caloric malnutrition, which
promotes catabolism and hypoalbuminemia. This is a
very delicate group of patients. While they are compensated, they already have extensive hepatic damage.
Malnutrition accelerates their slide towards decompensation, as there is a direct correlation between the
progression of the liver disease and the severity of
malnutrition.5,20
Patients with cirrhosis who are malnourished have a
higher rate of hepatic encephalopathy, infection, and
variceal bleeding.18,22 They are also twice as likely to
have refractory ascites.1 All of these events in a cirrhotic
have high mortality rates. Multiple studies have reported
a correlation between poor nutritional status and
mortality, and malnutrition is an independent predictor of
mortality in patients with cirrhosis.3,23 It is no wonder
then that the nutritionally worst group has the maximum
number of patients who have decompensated cirrhosis,
followed by CC.
Only 2 patients had a SGA score of 'A' in the DC group.
The majority (64%) were scoring the worst in malnutrition, while a significant number (34%) were moderately malnourished. Thus the slide into malnourishment
that begins in the stage of CHC becomes complete
when patients have DC.
The results also show that the transition from CHC to
DC is accompanied at all levels by worsening in
nutritional states, which was statistically significant.
Therefore, the need for nutritional intervention exists
at all stages. Utilizing modalities such as media
campaigns, out-patient counselling of patients, and
awareness camps may all serve to fight the disinformation that takes the place of correct information,
when it is not supplied by the health care provider.
Physicians should also be made aware of not only the
importance of nutritional evaluation and counselling in
all patients with hepatitis C infection but also its regular
assessment at follow-up visits.
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Patients should be encouraged to take as normal and
balanced a diet as possible, including protein, which is
routinely restricted in our local setting. The institution of
a bland, protein and calorie restricted diet is not
warranted, and should be counselled against at every
encounter with the patient and their attendants. Even in
advanced cirrhosis, protein should only be restricted
during a period of encephalopathy, and salt should be
restricted if there is pedal oedema and/or ascites.23,24
This study documents the baseline nutritional status of a
large cohort of patients in our setting, and provides data
upon which other nutrition interventional studies may
be based.

CONCLUSION
Patients at all stages of hepatitis C virus infection are
malnourished. It is imperative to assess the nutritional
status of all patients with HCV related liver disease and
to optimize nutrition in these patients.
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